Trial Profile
Nebivolol inhibition of coronary artery Smooth muscle cell proliferation after Coronary artery Intervention (NESCIO)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2008
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Pharmacodynamics
- Acronyms NESCIO
- 13 Mar 2008 New trial record.